University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
NIAID - National Institute of Allergy and Infectious Diseases
About This Grant
The University of North Carolina (UNC) Global HIV Prevention and Treatment Clinical Trials Unit (CTU) has a well-established record of high quality, innovative clinical research, strong network and scientific leadership. The CTU engages with critically important populations infected with and at high risk of HIV in southeastern US, southern Africa and southeast Asia. Our CTU is led by three experienced principal investigators (Joseph Eron MD, Mina Hosseinipour MD and David Wohl MD) and will support all four NIH Clinical Trials Networks (CTN); Adult Therapeutic Strategies, HIV Prevention, Vaccine Prevention and Pediatric, Adolescent and Maternal Therapeutic Strategies. Our four experienced Clinical Research Sites (CRS) include Chapel Hill CRS (Adult Strategies, Prevention and Vaccine CTN) led by Dr. Wohl, Greensboro CRS (Adult Strategies, Prevention and Vaccine CTN) led by Cornelius Van Dam MD, Malawi CRS (all four CTN) led by Lameck Chinula MD and Vietnam CRS (Adult Strategies, Prevention and Vaccine CTN) led by Vivian Go PhD. Participants with HIV include those newly diagnosed (including with acute infection), PWH stably suppressed on therapy, PWH with adherence challenges to care or medication, and PWH with drugresistant HIV. We will enroll PWH at risk for comorbidities and PWH or without HIV including those with co-epidemic pathogens such as tuberculosis (TB) and Hepatitis B virus (HBV) which affect USA populations but the higher disease prevalence in Malawi and Vietnam allows research efficiency. We have skilled, experienced clinical and translational investigators working hand-in-hand with junior investigators in US and international settings, who will engage and execute the network scientific agenda. A globally representative set of senior scientists and public health leaders on our Scientific and Strategic Advisory Group advise the CTU leadership team. The CTU administration has a highly organized structure that is responsive to our research teams and CRSs. Each CRS engages the communities representing the affected populations in an interactive, openminded way. State-of-art communication and experienced, outstanding and well-organized laboratory, pharmacy, regulatory, quality and data management support the CTU, CRSs. Using this robust framework the UNC Global CTU is positioned optimally to continue our scientific, and network leadership and clinical trials support to all four NIH HIV networks, contributing to the elimination of HIV and significant co-infections in the USA and globally.
Grant Summary
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit is a NIAID - National Institute of Allergy and Infectious Diseases grant providing up to $1K for university, nonprofit, healthcare org. Applications are due 2027-11-30 (open). Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $1K
2027-11-30
- 1Confirm your organization is eligible for University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit from NIAID - National Institute of Allergy and Infectious Diseases, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIAID - National Institute of Allergy and Infectious Diseases before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIAID - National Institute of Allergy and Infectious Diseases's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit: Frequently Asked Questions
Who is eligible for the University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit?
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit is offered by NIAID - National Institute of Allergy and Infectious Diseases and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit provide?
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit provides up to $1K per award from NIAID - National Institute of Allergy and Infectious Diseases. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit deadline?
Applications for University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit are due 2027-11-30 (open). Because deadlines can change, verify the date with the funder, NIAID - National Institute of Allergy and Infectious Diseases, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit?
To apply for University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIAID - National Institute of Allergy and Infectious Diseases.